Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance?

Text size

Pfizer

shares dropped sharply on Tuesday after the company’s 2022 sales guidance appeared to fall short of expectations.

The guidance that

Pfizer

(ticker: PFE) presented, however, doesn’t take into account future sales of Pfizer’s Covid-19 vaccine and antiviral, but only sales already made. The number…